Astrazeneca reported $901M in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 2.47B 1.48B
AstraZeneca AZN:LN USD 901M 739M
Astrazeneca AZN:US USD 901M 739M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Canopy Growth Corp WEED:CN CAD -261583000 39.78M
Corcept Therapeutics CORT:US USD 16.6M 18.01M
Drreddys Laboratories RDY:US INR 12.47B 1.34B
Eli Lilly And LLY:US USD 1.94B 486M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Genmab GEN:DC DKK 584M 2B
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Horizon Pharma HZNP:US USD 120.41M 15.43M
JAZZ PHA JAZZ:US USD -240724000 221.08M
Johnson & Johnson JNJ:US USD 3.52B 938M
Merk MRK:US USD 3.02B 231M
Novartis NOVN:VX USD 1.47B 107M
Pacira Pharmaceuticals PCRX:US USD -10102000 9.41M
Perrigo Ordinary Shares PRGO:US USD -23700000 25.7M
Pfizer PFE:US USD 5B 3.61B
Phibro Animal Health PAHC:US USD 7.21M 3.35M
Prestige Brands PBH:US USD 51.95M 928K
Roche Holding ROG:VX 3.89B 4.64B
Supernus Pharmaceuticals SUPN:US USD 25.48M 23.73M
Teva Pharmaceutical Industries TEVA:US USD -1222000000 1.28B
Valeant Pharmaceuticals VRX:CN USD -410000000 809M
Zoetis ZTS:US USD 461M 68M